Kelly Jason R
Reporting owner on Forms 3, 4 and 5, CIK 1845677.
Kelly Jason R reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-21.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| DNA · Ginkgo Bioworks Holdings, Inc.CIK 1830214 | director, officer (See remarks) | 1 | 2026-10-21 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| DNA · Ginkgo Bioworks Holdings, I…Class A Common Stock | 2026-10-19 | S sold | -45,682 | $10.143 | 129,065 | Form 4 |
| DNA · Ginkgo Bioworks Holdings, I…Class A Common Stock | 2026-10-16 | M exercised | +55,694 | 148,957 | Form 4 | |
| DNA · Ginkgo Bioworks Holdings, I…Class A Common Stock | 2026-10-16 | M exercised | +25,790 | 174,747 | Form 4 | |
| DNA · Ginkgo Bioworks Holdings, I…Restricted Stock Units, derivative | 2026-10-16 | M exercised | -55,694 | 18,564 | Form 4 | |
| DNA · Ginkgo Bioworks Holdings, I…Restricted Stock Units, derivative | 2026-10-16 | M exercised | -25,790 | 283,677 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001628280-26-066703 | Ginkgo Bioworks Holdings, Inc. | 2026-10-21 |